COVID-19: Study Finds Paxlovid Reduces Long COVID-19 Risk, Pfizer Shares Bivalent Vaccine Data
Nov. 8, 2022 ||A new report from the Department of Veterans Affairs indicates that Paxlovid can reduce risk of long COVID-19; new data show Pfizer bivalent COVID-19 booster vaccines substantially increase immune responses compared with monovalent vaccines.
view more »